Capital Finance
The Greater New York Hospital Association is pitching a $2.5 billion plan they say will ensure the financially distressed safety net hospitals throughout the state survive by paying the larger healthcare providers to integrate them into their own systems.
The project, announced on Sunday, will tack on 54,000 square feet to the current 119,000 square-foot structure and will encompass a new outpatient center on the first floor, a surgery suite on the second floor and private inpatient rooms on the third.
The Pardee Hospital Foundation has received $200,000 from the James H. Cummings Foundation and $150,000 from the Cannon Foundation to support ongoing renovations to the North Carolina hospital's operating rooms, part of the facility's Comprehensive Cancer Center Capital Campaign.
Biopharmaceutical company Emmaus Life Sciences has raised approximately $1.7 million in gross proceeds from the sale of common shares to Korea Bio Medical Science Institute as part of a collaboration agreement between the two companies.
Franciscan St. Elizabeth Health - Crawfordsville in Indiana has been waiting a long time for a new emergency room, and thanks to a $15 million investment from the Franciscan Alliance -- a group that owns 14 hospitals in the area -- it will finally get one.
The New York Genome Center, a nonprofit focusing on biomedical research and clinical care, could be $100 million richer thanks to a challenge grant from the Simons Foundation and The Carson Family Charitable Trust.
Venture capital funding for health information technology totaled $4.6 billion in 574 deals in 2015, according to Mercom Capital Group, a global communications and consulting firm that keeps tabs on VC investments.
Enthusiasm for gene therapy remains high this week at the annual J.P. Morgan Healthcare Conference, despite uneven clinical trials and uncertainty over pricing, according to published reports.
Investors are gathering in San Francisco this week for the annual J.P. Morgan healthcare conference, the sector's biggest financial event and one where many biotech deals are expected to be announced.
Standard & Poor's has warned Anthem, Cigna, Aetna and Humana that the substantial debt needed to finance the proposed mergers between them may cause their credit ratings to fall.